Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody-oligonucleotide conjugates: an emerging modality for precision RNA therapeutics.

Antibody therapeutics·2026
Same author

Redefining Drug Immune Recognition: A Radically Reconfigured Molecular Architecture Enables Broad Fentanyl-Class Protection.

Journal of medicinal chemistry·2026
Same author

Affinity-optimized TROP2 antibodies support potent antitumor activity in antibody-drug conjugates.

Antibody therapeutics·2026
Same author

Fentanyl-Rewired: A 2‑Azaspiro[3.3]heptane Core Preserves μ‑Opioid Function.

ACS medicinal chemistry letters·2026
Same author

CD44v9 as a therapeutic target for antibody-drug conjugate in advanced breast cancer.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Payload Diversification Overcomes Resistance and Guides Sequential Antibody-Drug Conjugate Therapy in Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Related Experiment Video

Updated: May 14, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Modulating cocaine vaccine potency through hapten fluorination.

Xiaoqing Cai1, Kyoji Tsuchikama, Kim D Janda

  • 1Department of Chemistry, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.

Journal of the American Chemical Society
|February 13, 2013
PubMed
Summary

Developing novel cocaine vaccines, researchers synthesized halogenated cocaine haptens. Fluorinated hapten GNF showed strong cocaine binding and increased antibody production, suggesting a promising new strategy for addiction treatment vaccines.

More Related Videos

The Use of Fluorescent Target Arrays for Assessment of T Cell Responses In vivo
12:09

The Use of Fluorescent Target Arrays for Assessment of T Cell Responses In vivo

Published on: June 19, 2014

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
08:13

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

Related Experiment Videos

Last Updated: May 14, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

The Use of Fluorescent Target Arrays for Assessment of T Cell Responses In vivo
12:09

The Use of Fluorescent Target Arrays for Assessment of T Cell Responses In vivo

Published on: June 19, 2014

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
08:13

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

Area of Science:

  • Immunology
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Cocaine addiction is a chronic relapsing disorder.
  • Antibody-based therapies offer a potential treatment avenue.
  • Current vaccine development requires enhanced immunogenicity.

Purpose of the Study:

  • To investigate halogenated cocaine haptens for improved anti-cocaine vaccine efficacy.
  • To design and synthesize novel fluorine- and chlorine-containing haptens.
  • To evaluate the immunological properties of these new haptens.

Main Methods:

  • Synthesis of four novel cocaine haptens (GNF, GNCF, GN5F, GNCl) based on succinyl norcocaine (SNC).
  • Assessment of hapten cocaine binding affinity.
  • Measurement of antibody concentrations elicited by the haptens in preclinical models.

Main Results:

  • Hapten GNF demonstrated potent cocaine affinity, comparable to SNC.
  • GNF elicited significantly higher antibody concentrations than the parent structure SNC.
  • Other synthesized haptens also showed potential, warranting further investigation.

Conclusions:

  • Strategic fluorination of cocaine haptens can enhance vaccine immunogenicity.
  • GNF represents a promising candidate for improving existing cocaine vaccines.
  • This hapten design approach may be applicable to vaccines for other drugs of abuse.